The Exchange had sought clarification from Hindustan Composites Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
HINDCOMPOS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NSE sought clarification from Hindustan Composites regarding financial results submitted for quarter ended 31-Mar-2026. The exchange noted that the filing format did not appear to comply with Schedule III of Companies Act 2013 or IND AS, with identical figures shown in standalone and consolidated results. The company clarified that its share of losses in joint venture Compo Advics India Private Limited exceeded its investment value, requiring discontinuation of loss recognition per IND AS 28 from FY 2021-22. The company added a 'Nil' entry for share of joint venture losses in consolidated results and clarified that segment asset and liability figures differ between standalone and consolidated statements. The company maintains its filing complies with regulatory requirements.
No material adverse impact on shareholders - this is a routine regulatory clarification confirming accounting treatment for an impaired joint venture investment and format compliance of financial disclosures.